Gueta, Racheli; Blaugrund, Eran; Bloomenfeld, Alon; Herbst, Karen L. Dermatologic Surgery: August 2021 – Volume 47 – Issue 8 –...
Read moreNews & Events
Raziel Announces China Market License Agreement with Fosun Pharma for RZL 012
REHOVOT, Israel, Sept. 17, 2020 /PRNewswire/ — Raziel Therapeutics, a Pharmaceutical company developing next-generation novel prescription products for the medical aesthetics market announces licensing...
Read more
Fat Melting Pharmaceutical Company Raziel Therapeutics Raises $22 Million in Series C Funding Round
REHOVOT, Israel, Dec. 18, 2019 /PRNewswire/ — Raziel Therapeutics a clinical-stage pharmaceutical company announces a $22 million Series C preferred stock financing led by Pontifax, with...
Read more
Scientific article : Mode of Action of RZL-012, a New Fat-Reducing Molecule
Blaugrund, Eran; Gueta, Racheli ; Zernov, Anton; Bloomenfeld, Alon, Dermatologic Surgery: December 2021 – Volume 47 – Issue 12 – p...
Read moreRaziel was selected as the Most Innovative Company of the year at AIS 2022 in San Diego
